Merino, Jose G. MD, MPhil; Editor-in-Chief, Neurology(R)
doi : 10.1212/WNL.0000000000013254
Volume 98(7), 15 February 2022, p 259-260
Fernandez, Eduardo MD, PhD
doi : 10.1212/WNL.0000000000013177
Volume 98(7), 15 February 2022, p 261-262
Beslow, Lauren A. MD, MSCE; Lo, Warren D. MD
doi : 10.1212/WNL.0000000000013201
Volume 98(7), 15 February 2022, p 263-264
Fifer, Matthew S. PhD*; McMullen, David P. MD*; Osborn, Luke E. PhD; Thomas, Tessy M. PhD; Christie, Breanne PhD; Nickl, Robert W. PhD; Candrea, Daniel N. BS; Pohlmeyer, Eric A. PhD; Thompson, Margaret C. PhD; Anaya, Manuel A. MD; Schellekens, Wouter PhD; Ramsey, Nick F. PhD; Bensmaia, Sliman J. PhD; Anderson, William S. MD, PhD; Wester, Brock A. PhD; Crone, Nathan E. MD; Celnik, Pablo A. MD; Cantarero, Gabriela L. PhD; Tenore, Francesco V. PhD
doi : 10.1212/WNL.0000000000013173
Volume 98(7), 15 February 2022, p e679-e687
The restoration of touch to fingers and fingertips is critical to achieving dexterous neuroprosthetic control for individuals with sensorimotor dysfunction. However, localized fingertip sensations have not been evoked via intracortical microstimulation (ICMS).
Li, Yan PhD; Schindler, Suzanne E. PhD; Bollinger, James G. PhD; Ovod, Vitaliy MS; Mawuenyega, Kwasi G. PhD; Weiner, Michael W. MD; Shaw, Leslie M. PhD; Masters, Colin L. MD; Fowler, Christopher J. PhD; Trojanowski, John Q. PhD; Korecka, Magdalena PhD; Martins, Ralph N. PhD; Janelidze, Shorena PhD; Hansson, Oskar MD, PhD; Bateman, Randall J. MD
doi : 10.1212/WNL.0000000000013211
Volume 98(7), 15 February 2022, p e688-e699
To determine the diagnostic accuracy of a plasma A[beta]42/A[beta]40 assay in classifying amyloid PET status across global research studies using samples collected by multiple centers that utilize different blood collection and processing protocols.
Chu, Winston Thomas PhD; Wang, Wei-en PhD; Zaborszky, Laszlo MD, PhD; Golde, Todd Eliot MD, PhD; DeKosky, Steven MD; Duara, Ranjan MD; Loewenstein, David A. PhD; Adjouadi, Malek PhD; Coombes, Stephen A. PhD; Vaillancourt, David E. PhD
doi : 10.1212/WNL.0000000000013206
Volume 98(7), 15 February 2022, p e700-e710
The goal of this work was to determine the relationship between diffusion microstructure and early changes in Alzheimer disease (AD) severity as assessed by clinical diagnosis, cognitive performance, dementia severity, and plasma concentrations of neurofilament light chain.
Kelly, Dearbhla M. MBBCh, DPhil, MRCPI; Pendlebury, Sarah T. FRCP, DPhil; Rothwell, Peter M. MD, PhD, FRCP, FMedSci
doi : 10.1212/WNL.0000000000013205
Volume 98(7), 15 February 2022, p e711-e720
Individuals with chronic kidney disease (CKD) appear to be at increased risk of cognitive impairment, with both vascular and neurodegenerative mechanisms postulated. To explore the vascular hypothesis, we studied the association between CKD and dementia before and after TIA and stroke.
Abgottspon, Stephanie MSc; Thaqi, Qendresa PhD; Steiner, Leonie PhD; Slavova, Nedelina MD; Grunt, Sebastian MD, PhD; Steinlin, Maja MD; Everts, Regula PhD
doi : 10.1212/WNL.0000000000013207
Volume 98(7), 15 February 2022, p e721-e729
To investigate the effect of age at pediatric arterial ischemic stroke on long-term cognitive outcome in order to identify patients particularly at risk for the development of long-term cognitive sequelae.
Zambon, Alberto A. MD, PhD*; Waldrop, Megan A. MD*; Alles, Roxane PhD; Weiss, Robert B. PhD; Conroy, Sara BS; Moore-Clingenpeel, Melissa MS; Previtali, Stefano MD, PhD+; Flanigan, Kevin M. MD+; on behalf of the Italian DMD Network and the United Dystrophinopathy Project
doi : 10.1212/WNL.0000000000013246
Volume 98(7), 15 February 2022, p e730-e738
To describe the phenotypic spectrum of dystrophinopathy in a large cohort of individuals with DMD exon 2 duplications (Dup2), who may be particularly amenable to therapies directed at restoring expression of either full-length dystrophin or nearly full-length dystrophin through utilization of the DMD exon 5 internal ribosome entry site (IRES).
Tanboon, Jantima MD; Inoue, Michio MD, PhD; Saito, Yoshihiko MD, PhD; Tachimori, Hisateru PhD; Hayashi, Shinichiro PhD; Noguchi, Satoru PhD; Okiyama, Naoko MD, PhD; Fujimoto, Manabu MD, PhD; Nishino, Ichizo MD, PhD
doi : 10.1212/WNL.0000000000013176
Volume 98(7), 15 February 2022, p e739-e749
Discoveries of dermatomyositis-specific antibodies (DMSAs) in patients with dermatomyositis raised awareness of various myopathologic features among antibody subtypes. However, only perifascicular atrophy and perifascicular myxovirus resistant protein A (MxA) overexpression were officially included as definitive pathologic criteria for dermatomyositis classification. We aimed to demonstrate myopathologic features in MxA-positive dermatomyositis to determine characteristic myopathologic features in different DMSA subtypes.
Creigh, Peter D. MD*; Du, Khai BS*; Wood, Elizabeth P. MA; Mountain, Joan BS; Sowden, Janet BSc; Charles, Julie AAS; Behrens-Spraggins, Steffen BS; Herrmann, David N. MBBCh
doi : 10.1212/WNL.0000000000013175
Volume 98(7), 15 February 2022, p e750-e758
The goal of this work was to establish age-, sex-, and body dimension-adjusted normal cutoff values for Meissner corpuscle (MC) densities via in vivo reflectance confocal microscopy (RCM), timed vibration sensory thresholds with a 128-Hz tuning fork, and touch-pressure sensory thresholds with standardized monofilaments for clinical and research application.
Krzywicka, Katarzyna MD, MPhil*; van de Munckhof, Anita MD*; Sanchez van Kammen, Mayte MD; Heldner, Mirjam R. MD, MSc; Jood, Katarina MD, PhD; Lindgren, Erik MD; Tatlisumak, Turgut MD, PhD; Putaala, Jukka MD, PhD; Kremer Hovinga, Johanna A. MD; Middeldorp, Saskia MD, PhD; Levi, Marcel M. MD, PhD; Cordonnier, Charlotte MD, PhD; Arnold, Marcel MD; Zwinderman, Aeilko H. MD, PhD; Ferro, Jose M. MD, PhD; Coutinho, Jonathan M. MD, PhD+; Aguiar de Sousa, Diana MD, PhD+
doi : 10.1212/WNL.0000000000013148
Volume 98(7), 15 February 2022, p e759-e768
Cerebral venous sinus thrombosis (CVST) as a part of the thrombosis and thrombocytopenia syndrome is a rare adverse drug reaction of severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) vaccination. Estimated background rate of CVST with thrombocytopenia is 0.1 per million per month. We assessed the age-stratified risk of CVST with and without thrombocytopenia after SARS-CoV-2 vaccination.
Benarroch, Eduardo MD
doi : 10.1212/WNL.0000000000013253
Volume 98(7), 15 February 2022, p 274-278
Govindarajan, Raghav MD; Vu, Anh-Thu N. MD, MS; Salas, Rachel Marie E. MD, MEd; Miller, Alexandra Michelle MD, PhD; Sandness, David J. MD; Said, Rana R. MD; Southerland, Andrew M. MD, MSc; Fernandez, Andres MD, MSEd; Romano, Sofia BS; Sennott, Brianna J. BS; Patino-Murillas, Jorge MD; Soni, Madhu MD; on behalf of the AAN Undergraduate Education Subcommittee and Education Committee
doi : 10.1212/WNL.0000000000013222
Volume 98(7), 15 February 2022, p 279-286
The standard neurology clinical experience in medical school focuses primarily on bedside patient encounters; however, the limitations of the clinical environment due to the current COVID-19 pandemic have accelerated the need for virtual curriculum development. To provide guidance to Neurology clerkship directors during this unprecedented time, the American Academy of Neurology (AAN) Undergraduate Education Subcommittee (UES) formed a workgroup to develop an outline for a virtual curriculum, provide recommendations, and describe models of integrating virtual curricula into the neurology clerkship. In this overview, we discuss different methods of virtual instruction, hybrid models of clerkship training and the challenges to its implementation, professionalism issues, and modification of feedback and assessment techniques specific to the virtual learning environment. We also offer suggestions for implementation of a hybrid virtual curriculum into the neurology clerkship. The virtual curriculum is intended to supplement the core neurology in-person clinical experience and should not be used for shortening or replacing the required neurology clinical clerkship.
Guterman, Elan L. MD, MAS; Lowenstein, Daniel H. MD; Sporer, Karl A. MD
doi : 10.1212/WNL.0000000000013248
Volume 98(7), 15 February 2022, p 287-288
Yoganathan, Sangeetha MD, DNB, DM; Kumar, Madhan MD, DCH; Sharma, Suvasini MD, DM; Patel, Smruti MD; Danda, Sumita MD, DM; Thomas, Maya MD, DM
doi : 10.1212/WNL.0000000000013209
Volume 98(7), 15 February 2022, p 289
Ojha, Piyush MBBS, MD, DM; Mahajan, Anshu MBBS, MD, DM; Pal, Tanmoy MBBS, MD, DNB; Dubey, Sudhir MBBS, MS, MCh; Goel, Gaurav MBBS, MD, DM
doi : 10.1212/WNL.0000000000013223
Volume 98(7), 15 February 2022, p 290-291
Roberts, Jodie I. MD, MSc; Woodward, Kristine MD, MSc; Kirton, Adam MD, MSc; Esser, Michael J. MD, PhD
doi : 10.1212/WNL.0000000000013181
Volume 98(7), 15 February 2022, p 292-295
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant condition that is linked to a myriad of neurologic complications arising from vascular malformations of the brain, spinal cord, and lungs. Our case describes a previously healthy 3-year-old male who presented to hospital with fever of unknown origin and was found to have a brain abscess stemming from a pulmonary arteriovenous malformation (PAVM). This etiology was identified after a period of diagnostic delay; the medical team was suspicious for a proximal embolic source due to the presence of multiple tiny infarcts seen on MRI of the brain, but transthoracic echocardiogram and head and neck angiogram were unremarkable. Fortunately, an enhanced CT of the chest was performed, identifying a moderately sized PAVM. PAVMs are associated with intracranial abscesses due to shunting and loss of the normal filtering effects of the lung capillary bed. Impaired pulmonary filtration can permit paradoxical thromboemboli and septic microemboli to enter systemic circulation, predisposing patients with PAVMs to cerebral abscess and ischemic stroke. Screening for PAVMs with contrast-enhanced echocardiogram or enhanced CT of the chest may be considered in patients with cryptogenic brain abscess or recurrent embolic stroke of unknown origin. PAVMs are often associated with hereditary hemorrhagic telangiectasia (HHT). As many features of HHT have delayed clinical manifestation, genetic testing for HHT should be considered in all people with PAVM, even in the absence of other clinical features. In our case, genetic testing returned positive, confirming a new diagnosis of HHT type 1.
Abu Libdeh, Amal MBBS; Ibrahim, Ahmed MBBCH
doi : 10.1212/WNL.0000000000013183
Volume 98(7), 15 February 2022, p e769-e773
Imtiaz, Hassan MD; Can, Afra MD; Tapos, Daniela MD; Weber, Amanda DO
doi : 10.1212/WNL.0000000000013143
Volume 98(7), 15 February 2022, p e774-e775
Xu, Conghui MD*; Lin, Jun MD*; Niu, Xiaodong MD; Li, Jin MD, PhD
doi : 10.1212/WNL.0000000000013151
Volume 98(7), 15 February 2022, p e776-e777
Lewis, Ariane MD; Galetta, Steven MD
doi : 10.1212/WNL.0000000000013255
Volume 98(7), 15 February 2022, p 296
Cao, Shugang; Xia, Mingwu
doi : 10.1212/WNL.0000000000013256
Volume 98(7), 15 February 2022, p 296-297
Vynckier, Jan; Seiffge, David Julian; Fischer, Urs
doi : 10.1212/WNL.0000000000013257
Volume 98(7), 15 February 2022, p 297
Do you want to add Medilib to your home screen?